These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 8962217
1. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral. Serafinowicz A, Gaciong Z, Baçzkowska T, Durlik M, Lao M. Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217 [No Abstract] [Full Text] [Related]
2. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral. Serafinowicz A, Gaciong Z, Baçzkowska T, Rell K, Lao M, Wałaszewski J. Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216 [No Abstract] [Full Text] [Related]
3. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral. Warrens AN, Salama A, Waters JB, Lechler RI. Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190 [No Abstract] [Full Text] [Related]
4. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune. Pescovitz MD, Henson S, Bodziak K, Book BK, Gonin J, Jindal RM, Leapman SB, Milgrom ML, Filo RS. Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189 [No Abstract] [Full Text] [Related]
5. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption. Chapman JR, O'Connell PJ, Bovington KJ, Allen RD. Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229 [No Abstract] [Full Text] [Related]
7. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method. First MR, Weiskittel P, Shah M, Peddi VR, Canafax D, Schroeder TJ. Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260 [No Abstract] [Full Text] [Related]
11. Conversion from Sandimmune to Neoral in stable heart transplant recipients. Pethig K, Ruhparwar A, Korn A, Christians U, Wahlers T. Transplant Proc; 1996 Aug; 28(4):2287-9. PubMed ID: 8769228 [No Abstract] [Full Text] [Related]
12. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients. Roth D, Miller J. Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204 [No Abstract] [Full Text] [Related]
16. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients. Steinmuller D, Dougherty J, Coutee J, Surek D, Swies G, Lewis R. Transplant Proc; 1997 Aug; 29(1-2):298-9. PubMed ID: 9123005 [No Abstract] [Full Text] [Related]
17. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation. Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K. Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219 [No Abstract] [Full Text] [Related]
18. Cyclosporine levels in diabetic (type 1) patients undergoing kidney and pancreas transplantation: role of a new galenica formulation. Storck M, Mickley V, Gräb C, Steinbach G, Abendroth D. Transplant Proc; 1994 Oct; 26(5):2996-8. PubMed ID: 7940946 [No Abstract] [Full Text] [Related]